Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fernando Bozza and Patrícia Bozza.
Fernando Bozza
Connection Strength
1.877
Patrícia Bozza
  1. Platelet-leukocyte interactions in the pathogenesis of viral infections. Platelets. 2022 Feb 17; 33(2):200-207.
    View in: PubMed
    Score: 0.239
  2. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020 12; 16(12):e1009127.
    View in: PubMed
    Score: 0.230
  3. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020 09 10; 136(11):1330-1341.
    View in: PubMed
    Score: 0.226
  4. Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals. Sci Rep. 2018 10 09; 8(1):14999.
    View in: PubMed
    Score: 0.197
  5. Platelets in Immune Response to Virus and Immunopathology of Viral Infections. Front Med (Lausanne). 2018; 5:121.
    View in: PubMed
    Score: 0.191
  6. Lung production of platelet-activating factor acetylhydrolase in oleic acid-induced acute lung injury. Prostaglandins Leukot Essent Fatty Acids. 2007 Jul; 77(1):1-8.
    View in: PubMed
    Score: 0.091
  7. In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. J Antimicrob Chemother. 2021 06 18; 76(7):1874-1885.
    View in: PubMed
    Score: 0.059
  8. Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021 May 19; 7(1):116.
    View in: PubMed
    Score: 0.059
  9. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil. Emerg Infect Dis. 2021 May; 27(5):1446-1453.
    View in: PubMed
    Score: 0.059
  10. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021 Mar 01; 7(1):43.
    View in: PubMed
    Score: 0.058
  11. Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study. Front Med (Lausanne). 2021; 8:630982.
    View in: PubMed
    Score: 0.058
  12. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production. Antimicrob Agents Chemother. 2020 09 21; 64(10).
    View in: PubMed
    Score: 0.056
  13. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo. PLoS Negl Trop Dis. 2019 01; 13(1):e0007072.
    View in: PubMed
    Score: 0.050
  14. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci Transl Med. 2017 Sep 27; 9(409).
    View in: PubMed
    Score: 0.046
  15. Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae. Sci Rep. 2017 08 25; 7(1):9409.
    View in: PubMed
    Score: 0.046
  16. Zika virus evolution and spread in the Americas. Nature. 2017 06 15; 546(7658):411-415.
    View in: PubMed
    Score: 0.045
  17. Platelet proteome reveals novel pathways of platelet activation and platelet-mediated immunoregulation in dengue. PLoS Pathog. 2017 May; 13(5):e1006385.
    View in: PubMed
    Score: 0.045
  18. Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication. Sci Rep. 2017 04 24; 7:46772.
    View in: PubMed
    Score: 0.045
  19. The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication. Sci Rep. 2017 01 18; 7:40920.
    View in: PubMed
    Score: 0.044
  20. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog. 2012 Dec; 8(12):e1003099.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.